STAT+: The IRS is probing UnitedHealth, and a private equity slowdown
Reported by STAT News · all stories from statnews.com
Editorial digest
The Internal Revenue Service is reportedly probing UnitedHealth Group and also examining a slowdown in private equity deals, indicating potential financial or compliance concerns.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/21/2026
STAT+: What’s the deal with Isomorphic Labs?
A new report examines the current standing and operations of drug discovery venture Isomorphic Labs.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/20/2026
STAT+: OpenEvidence’s JAMA paper leaves open questions
A recent journal publication regarding OpenEvidence still leaves several unanswered questions in medical technology.
- Trusted health newsroom10/23/2026
STAT+: AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
Pathos has secured $237 million in financing, elevating the artificial intelligence drugmaker's estimated value to $3 billion.
- Trusted health newsroom10/14/2026
STAT+: The startup chasing ‘general biological intelligence’
A new company is pursuing advanced biological AI capabilities.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.